European Journal of Chemistry

A new polymorph of 5-bromo ortho vanillin: Synthesis, characterization, crystal engineering, Hirshfeld surface, calculation of interaction energy, and energy frameworks

Crossmark


Main Article Content

Sourav Roy
Dhrubajyoti Majumdar
Dhiraj Das

Abstract

This article reports on one of the newly synthesized 5-bromo ortho vanillin (C8H7BrO3) (1) polymorphs, whose X-ray structure was determined by single crystal X-ray diffraction. The polymorph attains a monoclinic system, space group P21/c, V = 824.3(9), and Z = 4. In this work, the cell parameters observed are a = 4.080(2) Å, b = 20.733(12) Å, c = 9.844(7) Å, and β = 98.4(2). Polymorph 1 is compared with the reported compound 2. The article discusses the structural characterization of polymorph 1 using HRMS, FTIR, UV-vis, 1H/13C NMR, and 13C DEPT NMR spectroscopy, and explores NCSI (noncovalent supramolecular interactions) within the crystal network. Furthermore, the Hirshfeld surface and 2D fingerprint plot analyze the presence of significant H···Br (20.8%) and H···O (23.8%) contacts in the crystal assembly. In addition, interaction energies and energy frameworks have been calculated. The study revealed that the constructed frameworks fall into electrostatic (Eele, red cylinders) and dispersion (Edis, green cylinders) categories, along with total interaction energies (Etot, blue cylinders). The polymorph is rationalized using physicochemical, crystallographic, Hirshfeld surface, interaction energy and energy frameworks.


icon graph This Abstract was viewed 6 times | icon graph Article PDF downloaded 1 times icon graph Article CIF FILE downloaded 0 times icon graph Article CIF FILE downloaded 0 times icon graph Article SUPP. MATER. downloaded 0 times

How to Cite
(1)
Roy, S.; Majumdar, D.; Das, D. A New Polymorph of 5-Bromo Ortho Vanillin: Synthesis, Characterization, Crystal Engineering, Hirshfeld Surface, Calculation of Interaction Energy, and Energy Frameworks. Eur. J. Chem. 2026, 17, 168-175.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Chen, A.; Peng, Y.; Chen, Z.; Lu, Y.; Guo, M.; Cai, T. Crystal engineering for poorly water-soluble drugs: From design to applications. Acta Pharm. Sin. B 2026, 16 (4), 1848-1882.
https://doi.org/10.1016/j.apsb.2025.12.003

[2]. Rissanen, K. Crystallography and Crystal Engineering. Anal. Methods Supramol. Chem. 2012, 459-498.
https://doi.org/10.1002/9783527644131.ch10

[3]. Nangia, A. K.; Desiraju, G. R. Crystal Engineering: An Outlook for the Future. Angew. Chem. Int. Ed. 2019, 58 (13), 4100-4107.
https://doi.org/10.1002/anie.201811313

[4]. Higashi, K.; Ueda, K.; Moribe, K. Recent progress of structural study of polymorphic pharmaceutical drugs. Adv. Drug Deliv. Rev. 2017, 117, 71-85.
https://doi.org/10.1016/j.addr.2016.12.001

[5]. Aitipamula, S.; Banerjee, R.; Bansal, A. K.; Biradha, K.; Cheney, M. L.; Choudhury, A. R.; Desiraju, G. R.; Dikundwar, A. G.; Dubey, R.; Duggirala, N.; Ghogale, P. P.; Ghosh, S.; Goswami, P. K.; Goud, N. R.; Jetti, R. R.; Karpinski, P.; Kaushik, P.; Kumar, D.; Kumar, V.; Moulton, B.; Mukherjee, A.; Mukherjee, G.; Myerson, A. S.; Puri, V.; Ramanan, A.; Rajamannar, T.; Reddy, C. M.; Rodriguez-Hornedo, N.; Rogers, R. D.; Row, T. N.; Sanphui, P.; Shan, N.; Shete, G.; Singh, A.; Sun, C. C.; Swift, J. A.; Thaimattam, R.; Thakur, T. S.; Kumar Thaper, R.; Thomas, S. P.; Tothadi, S.; Vangala, V. R.; Variankaval, N.; Vishweshwar, P.; Weyna, D. R.; Zaworotko, M. J. Polymorphs, Salts, and Cocrystals: What's in a Name?. Cryst. Growth Des. 2012, 12 (5), 2147-2152.
https://doi.org/10.1021/cg3002948

[6]. Vippagunta, S. R.; Brittain, H. G.; Grant, D. J. Crystalline solids. Adv. Drug Deliv. Rev. 2001, 48 (1), 3-26.
https://doi.org/10.1016/S0169-409X(01)00097-7

[7]. Gao, L.; Dai, X.; Li, S.; Vasilev, N. A.; Perlovich, G. L.; Lu, T.; Chen, J. Effect of Polyamorphism on the Morphology, Dissolution, and Stability of Olaparib. Cryst. Growth Des. 2024, 24 (12), 4906-4913.
https://doi.org/10.1021/acs.cgd.3c00601

[8]. Gao, Z.; Rohani, S.; Gong, J.; Wang, J. Recent Developments in the Crystallization Process: Toward the Pharmaceutical Industry. Engineering 2017, 3 (3), 343-353.
https://doi.org/10.1016/J.ENG.2017.03.022

[9]. Kitamura, M. Strategy for control of crystallization of polymorphs. CrystEngComm 2009, 11 (6), 949-964.
https://doi.org/10.1039/b809332f

[10]. Brittain, H. G. Polymorphism in Pharmaceutical Solids, Second Edition; Informa Medical, 2009.

[11]. Censi, R.; Di Martino, P. Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs. Molecules 2015, 20 (10), 18759-18776.
https://doi.org/10.3390/molecules201018759

[12]. Nicoud, L.; Licordari, F.; Myerson, A. S. Estimation of the Solubility of Metastable Polymorphs: A Critical Review. Cryst. Growth Des. 2018, 18 (11), 7228-7237.
https://doi.org/10.1021/acs.cgd.8b01200

[13]. Agostini, S. B.; Borges, B. A.; de Araújo, M. B.; Bonfilio, R. Growing Interest in Pharmaceutical Cocrystals: A Comprehensive Review of Applications and Trends. ChemistrySelect 2025, 10 (30) e00831, https://doi.org/10.1002/slct.202500831.
https://doi.org/10.1002/slct.202500831

[14]. Malik, A. A.; Gupta, P.; Joseph, A. Crystal polymorphism: Applications and future prospects. AIP Conf. Proc. 2023, 2804, 020039.
https://doi.org/10.1063/5.0162838

[15]. Feng, Y.; Hao, H.; Chen, Y.; Wang, N.; Wang, T.; Huang, X. Enhancement of Crystallization Process of the Organic Pharmaceutical Molecules through High Pressure. Crystals 2022, 12 (3), 432.
https://doi.org/10.3390/cryst12030432

[16]. Saha, B. K.; Nath, N. K.; Thakuria, R. Polymorphs with Remarkably Distinct Physical and/or Chemical Properties. Chem. Rec. 2022, 23 (1), e202200173.
https://doi.org/10.1002/tcr.202200173

[17]. Parrish, D. A.; Deschamps, J. R.; Gilardi, R. D.; Butcher, R. J. Polymorphs of Picryl Bromide. Cryst. Growth Des. 2007, 8 (1), 57-62.
https://doi.org/10.1021/cg700727n

[18]. Gowrisankar, S.; Fokin, A. A.; Becker, J.; Mathew, N.; Schmedt auf der Günne, J.; Schreiner, P. R. Polymorphism and White Light Emission of 1‐Bromo‐3,5,7‐triphenyladamantane Compared with 1,3,5,7‐Tetraphenyladamantane. Eur J. Org Chem 2024, 27 (23), e202400260.
https://doi.org/10.1002/ejoc.202400260

[19]. Krishnapriya, B.; Malarselvi, R.; Raja, C.; Priscilla, R. Elucidation of crystal structures using Bragg's peaks and Nuclear Magnetic Resonance chemical shifts for polymorphic forms of (E)-4-Bromo-2-[(phenylimino)methyl]phenol. Chem. Phys. Impact 2023, 7, 100340.
https://doi.org/10.1016/j.chphi.2023.100340

[20]. Gilday, L. C.; Robinson, S. W.; Barendt, T. A.; Langton, M. J.; Mullaney, B. R.; Beer, P. D. Halogen Bonding in Supramolecular Chemistry. Chem. Rev. 2015, 115 (15), 7118-7195.
https://doi.org/10.1021/cr500674c

[21]. Usoltsev, A. N.; Sukhikh, T. S.; Novikov, A. S.; Shayapov, V. R.; Pishchur, D. P.; Korolkov, I. V.; Sakhapov, I. F.; Fedin, V. P.; Sokolov, M. N.; Adonin, S. A. Unexpected Polymorphism in Bromoantimonate(III) Complexes and Its Effect on Optical Properties. Inorg. Chem. 2021, 60 (4), 2797-2804.
https://doi.org/10.1021/acs.inorgchem.0c03699

[22]. Gavale, R.; Pandit, S. K.; Misra, R. Room Temperature Phosphorescence Driven by Mechanochromism. Chem. An Asian J. 2025, 20 (10), e202401893.
https://doi.org/10.1002/asia.202401893

[23]. Vega, D. R.; Halac, E.; Segovia, L.; Baggio, R. A New, More Stable Polymorphic Form of Otilonium Bromide: Solubility, Crystal Structure, and Phase Transformation. J. Pharm. Sci. 2016, 105 (10), 3013-3020.
https://doi.org/10.1016/j.xphs.2016.06.012

[24]. Negrier, P.; Barrio, M.; Tamarit, J. L.; Mondieig, D. Polymorphism in 2-X-Adamantane Derivatives (X = Cl, Br). J. Phys. Chem. B. 2014, 118 (32), 9595-9603.
https://doi.org/10.1021/jp505280d

[25]. Ye, W.; Zhang, C.; Sung, H. H.; Wong, L. W.; Sheong, F. K.; Williams, I. D. Effect of Molecular Perturbation on Polymorphism: The Case of 8-Halotheophyllines (8-Cl-Tph and 8-Br-Tph). Crystals 2025, 15 (4), 340.
https://doi.org/10.3390/cryst15040340

[26]. Kuang, Y.; Gao, X.; Niu, Y.; Shi, X.; Zhou, W. Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs. Molecules 2021, 26 (7), 1983.
https://doi.org/10.3390/molecules26071983

[27]. Berezin, A. Non-centrosymmetric triclinic polymorph of bis(triphenylphosphine oxide)copper(II) dibromide: Crystal structure, magnetic properties, and DFT calculations. J. Mol. Struct. 2026, 1353, 144733.
https://doi.org/10.1016/j.molstruc.2025.144733

[28]. Wang, L. P.; Liu, D. W.; Wang, G. P.; Qin, S. L.; Huang, S. P.; Wang, X. J. Study on Synthesis of 6-Bromo-2, 3-Dihydroxybenzaldehyde. Adv. Mat. Res. 2014, 1033-1034, 552-554.
https://doi.org/10.4028/www.scientific.net/AMR.1033-1034.552

[29]. Hanson, J. R.; Hitchcock, P. B.; Toche, F. The Conformation of Some ortho-bromoarylaldehydes. J. Chem. Res. 2008, 2008 (7), 416-418.
https://doi.org/10.3184/030823408785702562

[30]. Chakraborty, J.; Thakurta, S.; Samanta, B.; Ray, A.; Pilet, G.; Batten, S. R.; Jensen, P.; Mitra, S. Synthesis, characterisation and crystal structures of three trinuclear cadmium(II) complexes with multidentate Schiff base ligands. Polyhedron 2007, 26 (17), 5139-5149.
https://doi.org/10.1016/j.poly.2007.07.038

[31]. Bruker (2008). SMART, SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.

[32]. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71 , 3-8.
https://doi.org/10.1107/S2053229614024218

[33]. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A.; Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42 (2), 339-341.
https://doi.org/10.1107/S0021889808042726

[34]. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. A. Found Crystallogr. 2007, 64 (1), 112-122.
https://doi.org/10.1107/S0108767307043930

[35]. Sheldrick, G. M. SHELXTL: Software for Empirical Absorption Correction, Version 6.12; Bruker AXS Inc.: Madison, WI, 2001.

[36]. Majumdar, D.; Das, D.; Philip, J. E.; Tuzun, B.; Roy, S. Synthesis, Crystal Engineering, Density Functional Theory, ADME/T, Molecular Docking, and Antimicrobial Evaluation of Bromo‐Based Ortho‐Vanillin Compounds. ChemistrySelect 2025, 10 (35), e02364.
https://doi.org/10.1002/slct.202502364

[37]. Turner, M. J.; Grabowsky, S.; Jayatilaka, D.; Spackman, M. A. Accurate and Efficient Model Energies for Exploring Intermolecular Interactions in Molecular Crystals. J. Phys. Chem. Lett. 2014, 5 (24), 4249-4255.
https://doi.org/10.1021/jz502271c

[38]. Venkatesan, P.; Thamotharan, S.; Ilangovan, A.; Liang, H.; Sundius, T. Crystal structure, Hirshfeld surfaces and DFT computation of NLO active (2E)-2-(ethoxycarbonyl)-3-[(1-methoxy-1-oxo-3-phenylpropan-2-yl)amino] prop-2-enoic acid. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2016, 153, 625-636.
https://doi.org/10.1016/j.saa.2015.09.002

[39]. Turner, M. J.; Thomas, S. P.; Shi, M. W.; Jayatilaka, D.; Spackman, M. A. Energy frameworks: insights into interaction anisotropy and the mechanical properties of molecular crystals. Chem. Commun. 2015, 51 (18), 3735-3738.
https://doi.org/10.1039/C4CC09074H

[40]. Yuan, G.; Shao, K.; Du, D.; Wang, X.; Su, Z.; Ma, J. Secondary ligand-directed assembly of metal-organic coordination polymers based on a 2-(pyridin-4-yl)-1H-imidazole-4,5-dicarboxylic acid ligand: Syntheses, structures and photoluminescent properties. CrystEngComm. 2012, 14 (5), 1865-1873.
https://doi.org/10.1039/c1ce06178j

Supporting Agencies

The Central Laboratory of Tamralipta Mahavidyalaya and the Department of Chemistry, Tamluk-721636, Purba Medinipur, WB, India. Indian Institute of Technology (IIT) Jammu, Saptarshi Laboratory, Paloura campus, India. ,The Department of Chemistry and Chemical Technology, Vidyasagar University, Midnapore-721102, West Bengal, India.
Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

License Terms

by-nc

Copyright © 2026 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).